References
- Rodrigo L, Hernandez-Lahoz C, Fuentes D, Alvarez N, Lopez-Vazquez A, Gonzalez S. Prevalence of celiac disease in multiple sclerosis. BMC Neurol 2011;11:31.
- Nunez C, Dema B, Cenit MC, Polanco I, Maluenda C, Arroyo R, IL23R: a susceptibility locus for celiac disease and multiple sclerosis? Genes Immun 2008;9:289–93.
- Cammarota G, Cuoco L, Cianci R, Pandolfi F, Gasbarrini G. Onset of coeliac disease during treatment with interferon for chronic hepatitis C. Lancet 2000;356:1494–5.
- Sprenger R, Sagmeister M, Offner F. Acute ulcerative colitis during successful interferon/ribavirin treatment for chronic hepatitis. Gut 2005;54:438–9; author reply 9.
- Watanabe T, Inoue M, Harada K, Homma N, Uchida M, Ogata N, A case of exacerbation of ulcerative colitis induced by combination therapy with PEG-interferon alpha-2b and ribavirin. Gut 2006;55:1682–3.
- Musch E, Andus T, Kruis W, Raedler A, Spehlmann M, Schreiber S, Interferon-beta-1a for the treatment of steroid-refractory ulcerative colitis: a randomized, double-blind, placebo-controlled trial. Clin Gastroenterol Hepatol 2005;3:581–6.
- Rodrigues S, Magro F, Soares J, Nunes AC, Lopes S, Marques M, Case series: ulcerative colitis, multiple sclerosis, and interferon-beta 1a. Inflamm Bowel Dis 2010;16:2001–3.
- Mannon PJ, Hornung RL, Yang Z, Yi C, Groden C, Friend J, Suppression of inflammation in ulcerative colitis by interferon-beta-1a is accompanied by inhibition of IL-13 production. Gut 2011;60:449–55.
- Di Sabatino A, Pickard KM, Gordon JN, Salvati V, Mazzarella G, Beattie RM, Evidence for the role of interferon-alfa production by dendritic cells in the Th1 response in celiac disease. Gastroenterology 2007;133:1175–87.